Admin support for elite member ๐ฎ๐ณ
Sub: Investment for BIO- MANUFACTURING facility set up as per Pharma 4.0 suite AI, ML, Big data and Robotics.
Good investment opportunity for Global investors to invest in setting up of Biosimilar mAbs (High-concentration-low volume) manufacturing state-of-the-art facility (DS & DP) as per USFDA guidelines.
A greenfield & turnkey project to be based in Hyderabad, India spearheaded by industry-experts, biopharma professionals & scientists of international repute.
Total equity funding required is 165 crore INR (~ 20M USD) in four to five tranches @ 30 crore INR (4M USD) to 40 crore INR (5M USD) per tranche spread through 4-5 years.
Interested investors may please feel free to WhatsApp @ 9874182690 or email me at dasguptablr@hotmail.com
Thanks.
Debapriya Das Gupta
Founder Director
Pangene Biotech Ltd.
Kolkata
India ๐ฎ๐ณ